³Ô¹ÏºÚÁÏÍø of the key themes driving M&A activity reveals that big data accounted for seven medical devices deals announced in Q3 2024, worth a total value of $1.7m. The $1.5m minority acquisition of Guangdong Yinwei Decoding Biotechnology by Sino-Life Group and Zhongke Xunda Biotechnology (Shenzhen) was the industry’s largest disclosed deal. GlobalData’s ³Ô¹ÏºÚÁÏÍøs Industry Mergers and Acquisitions Deals by Top Themes in Q3 2024 report helps understand the pivotal themes steering M&A activity in the industry.
In value terms, big data-related deal activity decreased by 100% in Q3 2024 compared with the previous quarter’s total of $4.2bn. Related deal volume decreased by 13% in Q3 2024 versus the previous quarter and was 40% higher than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in 9M 2024 were Citigroup; Earlybird Venture Capital; lego corporate finance with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in 9M 2024 were Eversheds Sutherland (International); Greenberg Traurig; Kirkland & Ellis with 1, 1, 1 deals respectively.
For further understanding of GlobalData's ³Ô¹ÏºÚÁÏÍøs Industry Mergers And Acquisitions Deals By Top Themes In Q3 2024 – Strategic Intelligence,
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.